THE ALPHA-1 DOMAIN OF THE HLA-DR MOLECULE IS ESSENTIAL FOR HIGH-AFFINITY BINDING OF THE TOXIC SHOCK SYNDROME TOXIN-1

被引:113
作者
KARP, DR
TELETSKI, CL
SCHOLL, P
GEHA, R
LONG, EO
机构
[1] CHILDRENS HOSP MED CTR,DIV IMMUNOL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115
关键词
D O I
10.1038/346474a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
SEVERAL exoproteins from the bacterium Staphylococcus aureus are highly potent polyclonal activators of T cells in the presence of cells bearing class II antigens of the major histocompatibility complex (MHC)1-3. These toxins, including the toxic shock syndrome toxin (TSST-1), act at nanomolar concentrations, bind directly to class II molecules, and do not require the processing typical of nominal antigen3-7. Each toxin is capable of stimulating a subpopulation of peripheral T lymphocytes bearing particular Vβ sequences as part of their αβ T-cell receptors8,9. It is not known how these so-called 'superantigens' bind to class II and how this binding stimulates T cells. In this study, the different affinities of TSST-1 for human class II molecules DR and DP were exploited to define the region of a class II molecule necessary for high-affinity binding. Using chimaeric α- and β-chains of DR and DP expressed at the surface of transfected murine fibroblasts and a binding assay with TSST-1, it was shown that the α1 domain of DR is essential for high-affinity binding, and further that TSST-1 binding did not prevent subsequent binding of a DR-restricted antigenic peptide. This is compatible with a model of superantigen making external contacts with both class II and T cell receptor, and suggests that the Vβ portion of the T-cell receptor interacts with the nonpolymorphic α-chain of DR. © 1990 Nature Publishing Group.
引用
收藏
页码:474 / 476
页数:3
相关论文
共 20 条
[1]   THE EFFECTS OF MHC GENE DOSAGE AND ALLELIC VARIATION ON T-CELL RECEPTOR SELECTION [J].
BERG, LJ ;
FRANK, GD ;
DAVIS, MM .
CELL, 1990, 60 (06) :1043-1053
[2]  
BLOMSTERHAUTAMAA DA, 1986, J IMMUNOL, V137, P3572
[3]   A HYPOTHETICAL MODEL OF THE FOREIGN ANTIGEN-BINDING SITE OF CLASS-II HISTOCOMPATIBILITY MOLECULES [J].
BROWN, JH ;
JARDETZKY, T ;
SAPER, MA ;
SAMRAOUI, B ;
BJORKMAN, PJ ;
WILEY, DC .
NATURE, 1988, 332 (6167) :845-850
[4]   DEGENERATE BINDING OF IMMUNOGENIC PEPTIDES TO HLA-DR PROTEINS ON B-CELL SURFACES [J].
BUSCH, R ;
STRANG, G ;
HOWLAND, K ;
ROTHBARD, JB .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (05) :443-451
[5]   ANALYSIS OF THE MITOGENIC EFFECTS OF TOXIC SHOCK TOXIN ON HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS INVITRO [J].
CALVANO, SE ;
QUIMBY, FW ;
ANTONACCI, AC ;
REISER, RF ;
BERGDOLL, MS ;
DINEEN, P .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1984, 33 (01) :99-110
[6]  
CARLSSON R, 1988, J IMMUNOL, V140, P2484
[7]   INTERACTION OF STAPHYLOCOCCUS-AUREUS TOXIN SUPERANTIGENS WITH HUMAN T-CELLS [J].
CHOI, YW ;
KOTZIN, B ;
HERRON, L ;
CALLAHAN, J ;
MARRACK, P ;
KAPPLER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8941-8945
[8]  
COLE BC, 1990, J IMMUNOL, V144, P425
[9]   STRUCTURE-ACTIVITY RELATIONSHIP OF TOXIC-SHOCK-SYNDROME TOXIN-1 - DERIVATION AND CHARACTERIZATION OF IMMUNOLOGICALLY AND BIOLOGICALLY-ACTIVE FRAGMENTS [J].
EDWIN, C ;
PARSONNET, J ;
KASS, EH .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) :1287-1295
[10]  
FISCHER H, 1989, J IMMUNOL, V142, P3151